Drug therapy for advanced melanoma: a nursing perspective
The role of the skin cancer Clinical Nurse Specialist (CNS) in the UK is often confined to supporting patients with primary melanoma. The introduction of newly licensed drugs for advanced melanoma has provided new opportunities for the CNS to develop their expertise in this area. This article describes the key contributions that the skin cancer CNS may play in caring for patients receiving drug therapy for advanced melanoma.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
Publication date: September 1, 2015
More about this publication?
- Dermatological Nursing is the quarterly, peer-reviewed journal of the British Dermatological Nursing Group (BDNG) and the UK's only quality dermatological nursing journal. It aims to provide cutting-edge articles on the treatment and management of dermatological conditions and the care of patients with skin problems. While the focus is on dermatological nursing, the information included is relevant to other healthcare professionals.
- Membership Information
- Ingenta Connect is not responsible for the content or availability of external websites